Breast CancerGeneticsDiagnostics and screening
What this study is
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
Study details
- Sponsor
- Carol Fabian, MD
- Conditions
- Breast Cancer
- Enrolling
- 3,000 people
- Starts
- 1989-08
- Est. completion
- 2027-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 30 Years – 65 YearsSex FEMALEHealthy volunteers AcceptedYou may qualify if
- Women with at least 2 times the normal risk of developing breast cancer
- Between the ages of 30-65 (or within 10 years of youngest age at diagnosis in first degree relative)
- Greater than six months from ingestion of antihormonal therapy
- Greater than 1 year from pregnancy, lactation, or chemotherapy
- Willing to have a mammogram within six months prior to RPFNA
- Willing to discontinue NSAIDS or herbal supplements
- Willing to have blood drawn
You can't join if
- No metastatic malignancy of any kind
- No breast implants or tram flap reconstructions
- No radiation to both breasts
- No women who have a current mammogram or clinical breast exam suspicious for cancer
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUniversity of Kansas Medical Center
Kansas City, Kansas, United States
- Carol J Fabian, MD · Principal investigator
- Bruce Kimler, PhD · Principal investigator
Recruiting
Study team
Sponsor
Carol Fabian, MD
Study ID 4601
Principal investigator
Carol J Fabian, MD
University of Kansas Medical Center
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.